Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Eli Lilly is expanding its innovation digs to Beijing, opening two research centers called the Eli Lilly China Medical ...

Unger reports the following disclosures: serves as a consultant for the American Cancer Society, AstraZeneca and Loxo Oncology/ Eli Lilly Company, which is unrelated to the current work. Fred ...

ALBANY — Lilly Phillips began her college career as ... unselfish group that is working really hard.” Phillips is at the center of that as one of UAlbany’s co-captains for another season ...

The named manufacturer defendants are Indiana-based Eli Lilly and Co. and New Jersey-based ... The Attorney General asserts these three corporate actors control 80% of the pharmacy benefit ...

The US Food and Drug Administration confirmed Thursday that Eli Lilly (LLY) has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the ...

By considering the Debt-to-Equity ratio, Eli Lilly can be compared to its top 4 peers, leading to the following observations: Eli Lilly is positioned in the middle in terms of the debt-to-equity ...

It’s effectively the corporate equivalent of a credit card ... led to a sharp jump in the fortunes of Novo Nordisk and Eli Lilly — and of companies quick to produce copycat products.

If you’re on the fence about investing in Eli Lilly And Co or Novo Nordisk A/S (ADR ... The company operates Lilly Seaport Innovation Center (LSC), a research and development facility in the Boston ...

Eli Lilly's (NYSE: LLY) stock is up by more than 736% over the last five years, largely thanks to its best-selling medicines for type 2 diabetes and obesity. And while it likely has plenty of ...

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in ...